Open access · CC-BY
via OpenAlex
Plasma proteomic Alzheimer's risk score: Biological age clock and pseudotime trajectory
Shiwei Liu, Yen-Ning Huang, Tamina Park, Eun Hye Lee, Soumilee Chaudhuri, Nicholas K. Adzibolosu, Paula J. Bice, Jeffrey L. Dage, Jared R. Brosch, Sujuan Gao, Liana G. Apostolova, Donna M. Wilcock, Shannon L. Risacher, Andrew J. Saykin, Kwangsik T. Nho
Alzheimer s & Dementia · 2025 · ▲ 6 citations
Abstract
INTRODUCTION: Alzheimer's disease (AD) involves progressive cognitive decline. Plasma proteomics data may provide insights into disease risk and mechanisms. METHODS: Plasma proteomics data (N = 498) by the SomaScan 7k platform from the Indiana AD Research Center was used to calculate proteomics-based Alzheimer's risk scores: organ-specific aging clocks and pseudotime trajectory. The Alzheimer's risk scores were investigated for associations with plasma- and imaging-based biomarkers for AD and diagnosis and evaluated for classification performance for diagnosis and biomarker positivity status. RESULTS: Cognition-optimized brain and liver age acceleration showed significant associations with AD diagnosis and biomarkers. Pseudotime showed a molecular trajectory from cognitively normal to AD individuals, in association with plasma and imaging biomarkers. Previously known plasma biomarkers yielded better classification performance with inclusion of proteomics-based Alzheimer's risk scores. DISCUSSION: The findings highlight proteomics-derived biological aging clocks and pseudotime trajectory as potential biomarkers to complement current biomarker frameworks and identify disease mechanisms. HIGHLIGHTS: Plasma proteomic aging clocks and pseudotime provide potential markers for Alzheimer's disease (AD) risk. Cognition-optimized brain aging and pseudotime link to diagnosis and AD biomarkers. Brain aging clock and pseudotime improve the diagnosis classification performance. Pseudotime outperformed established plasma biomarkers for diagnosis classification.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1002/alz.70851
- Canonical
- link ↗
- Fetched
- 2026-11-16 MST
Cite this
APA
Liu, S., Huang, Y., Park, T., Lee, E.H., Chaudhuri, S., Adzibolosu, N.K., Bice, P.J., Dage, J.L., Brosch, J.R., Gao, S., Apostolova, L.G., Wilcock, D.M., Risacher, S.L., Saykin, A.J., & Nho, K.T. (2025). Plasma proteomic Alzheimer's risk score: Biological age clock and pseudotime trajectory. <em>Alzheimer s & Dementia</em>. https://doi.org/10.1002/alz.70851
Vancouver
Liu S, Huang Y, Park T, Lee EH, Chaudhuri S, Adzibolosu NK, et al. Plasma proteomic Alzheimer's risk score: Biological age clock and pseudotime trajectory. Alzheimer s & Dementia. 2025. doi:10.1002/alz.70851.
BibTeX
@article{shiwei2025Plasma,
title = {Plasma proteomic Alzheimer's risk score: Biological age clock and pseudotime trajectory},
author = {Shiwei Liu and Yen-Ning Huang and Tamina Park and Eun Hye Lee and Soumilee Chaudhuri and Nicholas K. Adzibolosu and Paula J. Bice and Jeffrey L. Dage and Jared R. Brosch and Sujuan Gao and Liana G. Apostolova and Donna M. Wilcock and Shannon L. Risacher and Andrew J. Saykin and Kwangsik T. Nho},
journal = {Alzheimer s & Dementia},
year = {2025},
doi = {10.1002/alz.70851},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Free Radical Biology and Medicine 2016
Preprint · OA
Energy metabolism and inflammation in brain aging and Alzheimer’s disease
BMC Medicine 2026
Open access · CC-BY
CardioMetAge estimates cardiometabolic aging and predicts disease outcomes
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2011
Open access · OA
Brain aging, Alzheimer's disease, and mitochondria
Proteomes 2016
Open access · CC-BY
The Role of Clinical Proteomics, Lipidomics, and Genomics in the Diagnosis of Alzheimer’s Disease
Journal of Alzheimer s Disease 2022
Preprint · OA
Salivary Proteomics Reveals Significant Changes in Relation to Alzheimer’s Disease and Aging
GeroScience 2024
Open access · CC-BY